Tibet Weixinkang Medicine Co Ltd Total Liabilities
Tibet Weixinkang Medicine Co Ltd total liabilities. Based on the latest financial reports, Tibet Weixinkang Medicine Co Ltd (603676) has total liabilities worth CN¥423.85 Million CNY (≈ $62.02 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 603676 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Tibet Weixinkang Medicine Co Ltd (2013–2025)
Total liabilities of Tibet Weixinkang Medicine Co Ltd from 2013 to 2025. This chart illustrates how Tibet Weixinkang Medicine Co Ltd's total liabilities have evolved over time, based on quarterly financial data.
Tibet Weixinkang Medicine Co Ltd Competitors by Total Liabilities
The table below lists competitors of Tibet Weixinkang Medicine Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shenzhen Prince New Materials Co Ltd
SHE:002735
|
China | CN¥1.49 Billion |
|
Jiangsu Yike Food Group Co.Ltd
SHE:301116
|
China | CN¥3.57 Billion |
|
Zhejiang Starry Pharm Co Ltd
SHG:603520
|
China | CN¥3.69 Billion |
|
Inox Green Energy Services Limited
NSE:INOXGREEN
|
India | Rs3.98 Billion |
|
Shenzhen Soling Industrial Co Ltd
SHE:002766
|
China | CN¥187.91 Million |
|
Assure Tech Hangzhou Co Ltd
SHG:688075
|
China | CN¥611.60 Million |
|
Jiangsu Jiangnan High Polymer Fiber Co Ltd
SHG:600527
|
China | CN¥93.96 Million |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
|
China | CN¥88.79 Million |
Liability Composition Analysis (2013–2025)
This chart breaks down Tibet Weixinkang Medicine Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Tibet Weixinkang Medicine Co Ltd asset portfolio.
Liquidity & Leverage Metrics
Tibet Weixinkang Medicine Co Ltd Total Liabilities Ratios Explained
Tibet Weixinkang Medicine Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.62 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tibet Weixinkang Medicine Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tibet Weixinkang Medicine Co Ltd (2013–2025)
The table below shows the annual total liabilities of Tibet Weixinkang Medicine Co Ltd from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥390.49 Million ≈ $57.14 Million |
-16.61% |
| 2024-12-31 | CN¥468.24 Million ≈ $68.52 Million |
+7.26% |
| 2023-12-31 | CN¥436.55 Million ≈ $63.88 Million |
-1.71% |
| 2022-12-31 | CN¥444.13 Million ≈ $64.99 Million |
+3.70% |
| 2021-12-31 | CN¥428.31 Million ≈ $62.67 Million |
+13.65% |
| 2020-12-31 | CN¥376.85 Million ≈ $55.15 Million |
+0.61% |
| 2019-12-31 | CN¥374.56 Million ≈ $54.81 Million |
+11.04% |
| 2018-12-31 | CN¥337.33 Million ≈ $49.36 Million |
+112.71% |
| 2017-12-31 | CN¥158.58 Million ≈ $23.21 Million |
+70.64% |
| 2016-12-31 | CN¥92.94 Million ≈ $13.60 Million |
-12.18% |
| 2015-12-31 | CN¥105.82 Million ≈ $15.49 Million |
+37.27% |
| 2014-12-31 | CN¥77.09 Million ≈ $11.28 Million |
+25.31% |
| 2013-12-31 | CN¥61.52 Million ≈ $9.00 Million |
-- |
About Tibet Weixinkang Medicine Co Ltd
Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China. It offers APIs; multivitamins and pediatric multivitamins for injections; concentrate of trace elements solution for infusion; compound and pediatric compound amino acid injections; iron sucrose, multiple electrolytes, potassium aspartate and magnesium… Read more